Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer

Shafquat Azim, Haseeb Zubair, Sanjeev K. Srivastava, Arun Bhardwaj, Asif Zubair, Aamir Ahmad, Seema Singh, Moh'D Khushman, Ajay P. Singh

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

We have recently demonstrated that the transcription factor MYB can modulate several cancer-Associated phenotypes in pancreatic cancer. In order to understand the molecular basis of these MYB-Associated changes, we conducted deep-sequencing of transcriptome of MYB-overexpressing and-silenced pancreatic cancer cells, followed by in silico pathway analysis. We identified significant modulation of 774 genes upon MYB-silencing (p < 0.05) that were assigned to 25 gene networks by in silico analysis. Further analyses placed genes in our RNA sequencing-generated dataset to several canonical signalling pathways, such as cell-cycle control, DNA-damage and-repair responses, p53 and HIF1α. Importantly, we observed downregulation of the pancreatic adenocarcinoma signaling pathway in MYB-silenced pancreatic cancer cells exhibiting suppression of EGFR and NF- B. Decreased expression of EGFR and RELA was validated by both qPCR and immunoblotting and they were both shown to be under direct transcriptional control of MYB. These observations were further confirmed in a converse approach wherein MYB was overexpressed ectopically in a MYB-null pancreatic cancer cell line. Our findings thus suggest that MYB potentially regulates growth and genomic stability of pancreatic cancer cells via targeting complex gene networks and signaling pathways. Further in-depth functional studies are warranted to fully understand MYB signaling in pancreatic cancer.

Original languageEnglish
Article number28446
JournalScientific reports
Volume6
DOIs
StatePublished - Jun 29 2016

Fingerprint

Dive into the research topics of 'Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer'. Together they form a unique fingerprint.

Cite this